TRT(SH:600085) Nan Fang Du Shi Bao·2025-12-20 13:37Core Viewpoint - The incident involving "Tongrentang Antarctic Krill Oil" has raised significant concerns due to the product's reported phospholipid content being zero, leading to investigations and legal actions against the involved companies [1][3][4]. Group 1: Investigation and Legal Actions - The Chengdu Xindu District Market Supervision Administration has established a joint investigation team to look into Beijing Tongrentang (Sichuan) Health Pharmaceutical Co., Ltd. and has initiated legal proceedings against the company [1][3]. - Beijing Tongrentang Health Pharmaceutical Co., Ltd. has ordered the cessation of sales of the implicated product and is conducting a full process review and traceability of the product [4]. - The Shanghai Consumer Protection Commission has raised questions regarding the accountability and beneficiaries of the alleged counterfeit and fraudulent activities related to the product [4]. Group 2: Company Responses and Consumer Protection - Beijing Tongrentang Group has issued an apology and stated that it will pursue legal responsibility for trademark infringement against Sichuan Health, Habbo Pharmaceutical, and related e-commerce platforms [4][5]. - The Shanghai Consumer Protection Commission has welcomed the proactive stance of Beijing Tongrentang Group and emphasized the importance of maintaining the brand's reputation, which has been built over 356 years [5].